phrykt

Personalis, Inc. (PSNL): who owns it and who trades it

As of Nov 16, 2026, PSNL insiders reported 16 open-market sales worth $9M and 12 purchases worth $2.7M in the last 12 months, with 92% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christopher M Hall (CEO), with $4.5M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Personalis

From the latest filings

Overall: more buying than selling. Funds, insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PSNL

158 funds and institutions reported PSNL shares worth $1.1B at the end of Q2 2026, about 81% of the company. The largest holder is Merck & Co., Inc. with 13.4%.

Funds and institutions (13F) 81%Everyone else 19%

10 largest owners, by share of the company

Merck & Co., Inc.13.4%
ARK Investment Management LLC7.9%
BlackRock, Inc.6.8%
Lightspeed Management Company, L.l.c.5.8%
Ameriprise Financial Inc5.8%
Deep Track Capital, LP3.8%
Aberdeen Group plc3.6%
Vanguard Capital Management LLC2.9%
Casdin Capital, LLC2.4%
Kennedy Capital Management LLC2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Merck & Co., Inc.14.04M13.41%$188MNo change
ARK Investment Management LLC8.27M7.90%$111M+4%
BlackRock, Inc.7.08M6.76%$94.9M+31%
Lightspeed Management Company, L.l.c.6.10M5.83%$81.8M-25%
Ameriprise Financial Inc6.09M5.81%$81.6M-20%
Deep Track Capital, LP4.00M3.82%$53.6M+33%
Aberdeen Group plc3.75M3.58%$50.2M+7%
Vanguard Capital Management LLC3.01M2.87%$40.3M+5%
Casdin Capital, LLC2.55M2.44%$34.2M+59%
Kennedy Capital Management LLC2.36M2.26%$31.7M+8%
Geode Capital Management, LLC1.82M1.74%$24.4M+40%
Bank of America Corp1.82M1.74%$24.4M+1536%
AIGH Capital Management LLC1.72M1.64%$23M-41%
Blue Water Life Science Advisors, LP1.68M1.60%$22.5MNo change
Dimensional Fund Advisors LP1.50M1.43%$20.1M+40%
State Street Corp1.49M1.42%$19.9M+31%
Morgan Stanley1.27M1.21%$17M+436%
Goldman Sachs Group Inc931,0310.89%$12.5M+26%
Hrt Financial LP930,8160.89%$12.5M+346%
Nuveen, LLC753,0040.72%$10.1M+119%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PSNL insiders reported $2.7M of open-market purchases and $9M of sales. 92% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$2.7M
12 trades, 1 people
Sales, 12 months
$9M
16 trades, 4 people
Sales under a 10b5-1 plan
92%
Share of sale value
Latest trade
Nov 3, 2026
Filed Nov 4, 2026

Purchases and sales by month

$3M$3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 3, 2026Christopher M HallCEOSale29,112$15.87$462KForm 4
Sep 18, 2026Stephen Michael MooreVice presidentSale2,068$16.22$33.5KForm 4
Sep 18, 2026Richard ChenPresidentSale3,998$16.22$64.8KForm 4
Sep 18, 2026Christopher M HallCEOSale7,459$16.22$121KForm 4
Sep 18, 2026Aaron TachibanaCFOSale2,931$16.22$47.5KForm 4
Jul 15, 2026Richard ChenPresidentSale plan100,000$15.15$1.5MForm 4
Jul 9, 2026Christopher M HallCEOSale plan100,000$15.08$1.5MForm 4
Jun 29, 2026Aaron TachibanaCFOSale plan4,982$14.00$69.7KForm 4
Jun 26, 2026Aaron TachibanaCFOSale plan51,251$13.18$675KForm 4
Jun 26, 2026Christopher M HallCEOSale plan100,000$13.15$1.3MForm 4
Jun 4, 2026Aaron TachibanaCFOSale plan40,000$12.01$480KForm 4
May 29, 2026Christopher M HallCEOSale plan80,091$11.02$883KForm 4
May 29, 2026Aaron TachibanaCFOSale plan38,799$11.58$449KForm 4
May 28, 2026Christopher M HallCEOSale plan19,909$11.02$219KForm 4
Jan 22, 2026Aaron TachibanaCFOSale plan1,201$11.50$13.8KForm 4
Dec 22, 2025Tempus AI, Inc.10% ownerPurchase28,000$8.93$250KForm 4
Dec 19, 2025Tempus AI, Inc.10% ownerPurchase29,641$8.39$249KForm 4
Dec 18, 2025Tempus AI, Inc.10% ownerPurchase31,430$7.91$249KForm 4
Dec 17, 2025Tempus AI, Inc.10% ownerPurchase31,650$7.86$249KForm 4
Nov 25, 2025Tempus AI, Inc.10% ownerPurchase13,888$11.00$153KForm 4
Nov 25, 2025Tempus AI, Inc.10% ownerPurchase9,712$10.08$97.9KForm 4
Nov 25, 2025Aaron TachibanaCFOSale plan103,668$10.78$1.1MForm 4
Nov 24, 2025Tempus AI, Inc.10% ownerPurchase25,225$9.87$249KForm 4
Nov 21, 2025Tempus AI, Inc.10% ownerPurchase9,900$8.84$87.5KForm 4
Nov 21, 2025Tempus AI, Inc.10% ownerPurchase16,599$9.74$162KForm 4
Nov 20, 2025Tempus AI, Inc.10% ownerPurchase28,827$8.63$249KForm 4
Nov 19, 2025Tempus AI, Inc.10% ownerPurchase30,645$8.12$249KForm 4
Nov 18, 2025Tempus AI, Inc.10% ownerPurchase64,750$7.67$497KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Christopher M HallChief Executive Officer, Director–$4.5MNov 3, 2026
Aaron TachibanaCFO AND COO–$2.9MSep 18, 2026
Tempus AI, Inc.10% owner$2.7M–Dec 22, 2025
Richard ChenPresident and CMO–$1.6MSep 18, 2026
Stephen Michael MooreSVP and Chief Legal Officer–$33.5KSep 18, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PSNL short interest

Moderate short interest. 6.2% of PSNL shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 51%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 6.75M PSNL shares were sold short, 6.2% of the shares outstanding, down 0.7% from the report before. At the average daily volume of 2.02M shares, buying them all back would take about 3.3 trading days (days to cover).

Shares short, % of all shares

6.22%May 15Oct 3014.1%

Days to cover

3.3May 15Oct 306.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20266.75M6.22%-1%2.02M3.3
Oct 15, 20266.79M6.36%-19%2.57M2.6
Sep 30, 20268.43M7.89%+2%1.95M4.3
Sep 15, 20268.27M7.74%-1%2.33M3.5
Aug 31, 20268.38M7.85%-0%4.67M1.8
Aug 14, 20268.40M7.86%-4%2.33M3.6
Jul 31, 20268.71M8.16%-21%5.15M1.7
Jul 15, 202611.10M10.60%-2%4.75M2.3
Jun 30, 202611.31M10.80%+2%4.07M2.8
Jun 15, 202611.10M10.60%-13%3.09M3.6
May 29, 202612.83M12.25%-7%2.98M4.3
May 15, 202613.73M13.12%+5%2.43M5.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Personalis company events

Personalis filed 15 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 6, 2026AnnouncementAs previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Tempus AI, Inc., a Nevada corporation, Aviary Development, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent, and Toucan Development… Filing
  3. Aug 20, 2026AnnouncementPersonalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP). Filing
  4. Aug 4, 2026ResultsReleased financial results. Filing
  5. Jul 20, 2026AgreementPersonalis, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger by and among the Company, Tempus AI, Inc., a Nevada corporation, Aviary Development, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent and Toucan Development, LLC, a Nevada limited liability… Filing
  6. Jul 20, 2026ResultsReleased financial results. Filing
  7. May 20, 2026AnnouncementOn May19, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for Personalis, Inc.’s ultrasensitive NeXT Personal ® test to include monitoring treatment response to neoadjuvant therapy (NAT) in patients diagnosed with Stage II-III… Filing
  8. May 13, 2026VoteReported shareholder vote results. Filing
  9. May 13, 2026AnnouncementOn May12, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for our ultrasensitive NeXT Personal ® test to include immunotherapy monitoring for patients with late-stage solid tumors. Filing
  10. May 7, 2026ResultsReleased financial results. Filing
  11. Mar 17, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
  12. Feb 26, 2026ResultsReleased financial results. Filing
  13. Jan 8, 2026ResultsReleased financial results. Filing
  14. Nov 28, 2025AnnouncementPersonalis, Inc. filed a prospectus supplement to the prospectus included in the Company’s shelf registration statement on Form S-3 (Registration No. 333-276204), relating to the offer and sale of up to $100 million of shares of the Company’s common stock pursuant to that certain Amended and… Filing
  15. Nov 25, 2025AnnouncementThe Centers for Medicare & Medicaid Services Molecular Diagnostics Program revised its reimbursement rate determination for Medicare coverage for our ultrasensitive NeXT Personal ® test for post-treatment surveillance of cancer recurrence in patients with stage II and III breast cancer. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Personalis financials

Famous investors that hold PSNL

5 of the 50 well-known investors we track reported holding PSNL in their latest 13F filing. The largest position is Cathie Wood's, worth $116M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Cathie Wood · ARK Investment ManagementQ3 20267.12M$116M0.7%-14%
Israel Englander · Millennium ManagementQ3 20261.11M$18M0.0%+146%
George Soros · Soros Fund ManagementQ3 2026250,000$4.1M0.1%New
Ken Griffin · Citadel AdvisorsQ3 2026132,235$2.2M0.0%-9%
Steve Cohen · Point72 Asset ManagementQ3 2026126,427$2.1M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PSNL in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Ameriprise Financial, Inc.13G/A1.0%
Nov 16, 2026Ameriprise Financial, Inc.13G/A1.0%
Nov 13, 2026ARK Investment Management LLC13G/A6.7%
Nov 13, 2026ARK Investment Management LLC13G/A6.7%

Questions about Personalis, Inc. (PSNL) stock

Who owns the most PSNL stock?

The largest reported owner of Personalis, Inc. (PSNL) is Merck & Co., Inc., with 13.4% of the company. In total, 158 funds and institutions reported holding PSNL at the end of Q2 2026, together about 81% of the shares. See the largest owners.

Are PSNL insiders buying or selling?

In the last 12 months, PSNL insiders reported 12 open-market purchases worth $2.7M and 16 sales worth $9M. The latest trade was on Nov 3, 2026. See every trade.

What is the short interest in PSNL?

As of Oct 30, 2026, 6.75M PSNL shares were sold short, 6.2% of the shares outstanding, down 0.7% from the report before. At the average daily volume of 2.02M shares, buying them all back would take about 3.3 trading days (days to cover). See the history.

Which famous investors hold PSNL?

5 of the 50 well-known investors we track reported PSNL in their latest 13F filing, including Cathie Wood, Israel Englander, George Soros. The largest position is worth $116M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.